We use essential cookies (authentication, your saved goals/stack) by default. With your permission we’ll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more about cookies
Triphala (Three-Fruit Ayurvedic Blend)
A classic Ayurvedic blend of three fruits — Amalaki (Emblica officinalis), Bibhitaki (Terminalia bellerica), and Haritaki (Terminalia chebula) — used for centuries as a gentle laxative and digestive/'rejuvenative' tonic. It modulates the gut microbiome and has antioxidant, antimicrobial, and anti-inflammatory activity. Human evidence is mostly small trials (often dental/oral or skin) plus animal and in-vitro work; large digestive efficacy trials are lacking.
What the evidence says
Most Triphala studies are mechanism or observational rather than RCTs that measure a clinical effect — keep findings provisional.
Most evidence is from high-quality meta-analyses and randomised trials published 2005–2026 with a typical study size of 104 participants.
Based on 22 studies · 1 meta-analysis · 15 RCTs · 14,180 total participants
Confidence
High confidenceBy outcome
Emerging 3.5 reflects only small human RCTs in dental and dermatology niches plus animal/in-vitro work; the core digestive and metabolic claims rest on tradition, not large trials.
16 rigorous studies
13 randomized trials · 2 meta-analyses · 1 systematic reviews
Our evidence rating for Triphala is accountable to this entire body of rigorous research indexed in PubMed — not a hand-picked subset.
PubMed · as of Jul 2026
2 trials ongoing or recruiting · 7 completed on ClinicalTrials.gov
Registered trials show research momentum for Triphala, not proof of effect — a registration is a plan, and posted results are sponsor-reported, not peer-reviewed. They are never counted toward the evidence rating above.
Browse these trials on ClinicalTrials.govClinicalTrials.gov · as of Sep 2026
Under EU law (Reg. 1924/2006), EFSA reviews whether a specific health claim for Triphala meets the evidence standard. These are independent regulatory decisions on claims — not studies, and never counted toward the evidence score above.
“Not authorised” means the specific claim wording did not meet the EU’s evidence standard — often a matter of dossier or phrasing, not proof of no effect. EFSA judges marketing claims and is kept separate from our study-based evidence score.
Source: EU Register of nutrition and health claims (European Commission / EFSA) · register snapshot Feb 2013
Triphala is a cornerstone Ayurvedic polyherbal made of equal parts of three dried fruits: Amalaki (Emblica officinalis), Bibhitaki (Terminalia bellerica), and Haritaki (Terminalia chebula).
It is traditionally taken as a mild, non-habit-forming laxative and as a 'rejuvenative' (rasayana) tonic for the gastrointestinal tract.
Its polyphenols (gallic acid, chebulinic acid, ellagic acid, tannins) act as antioxidants and modulate the gut microbiome — promoting Bifidobacteria and Lactobacillus while curbing less desirable microbes — and the formula shows antimicrobial, anti-inflammatory, immunomodulatory, and (in preclinical models) hypoglycemic and antineoplastic activity.
The honest evidence picture: most human data come from small trials in dentistry (as a mouthwash/irrigant comparable to chlorhexidine) and dermatology (a placebo-controlled trial showing reduced scalp sebum), while the digestive, metabolic, and anticancer claims rest largely on traditional use, narrative reviews, and animal/in-vitro studies.
Triphala is broadly well-tolerated, but its widely promoted digestive and metabolic benefits have not been confirmed in large, well-controlled clinical trials.
Polyphenols promote beneficial Bifidobacteria and Lactobacillus while inhibiting undesirable gut microbes, and are metabolized by gut bacteria into anti-inflammatory compounds.
Traditionally used as a mild, non-habit-forming laxative and bowel tonic, attributed to its tannin and anthraquinone-like constituents.
Rich in gallic acid, chebulinic acid, and ellagic acid; scavenges reactive oxygen species and lowers inflammatory signaling in preclinical models.
How Triphala works — from molecular targets to health outcomes. Click an edge to see supporting research.This visualization is in beta — pathways are being refined and expanded.
Monitor blood glucose given possible additive hypoglycemic effect.
Traditionally avoided in pregnancy (Haritaki content) — avoid.
Preclinical hypoglycemic activity could add to glucose-lowering drugs — monitor blood sugar.
Tannins and the laxative effect could reduce absorption of co-taken medications — separate dosing by 1-2 hours.
Terminalia constituents show antiplatelet activity that could add to blood-thinning drugs — monitor for bruising/bleeding.
Tip: Start low and increase gradually; reduce dose if stools become too loose
Tip: Use capsules or mix powder with warm water/honey
Triphala has an evidence score of 3.5/10 — emerging evidence based on 20 indexed studies. A classic Ayurvedic blend of three fruits — Amalaki (Emblica officinalis), Bibhitaki (Terminalia bellerica), and Haritaki (Terminalia chebula) — used for centuries as a gentle laxative and digestive/'rejuvenative' tonic. It modulates the gut microbiome and has antioxidant, antimicrobial, and anti-inflammatory activity. Human evidence is mostly small trials (often dental/oral or skin) plus animal and in-vitro work; large digestive efficacy trials are lacking. Representative study: PMID 32698634.
The commonly studied dose of Triphala is 500-2000mg powder/extract daily (traditional use often 1g once or twice daily); trials have used ~1g twice daily. Individual needs vary — start at the lower end of the range and adjust based on how you respond.
The best time to take Triphala is in the evening. It can be taken on an empty stomach. Traditionally taken on an empty stomach, often at night, for the laxative/digestive effect; can be taken with water.
Triphala is generally well-tolerated and considered safe for most healthy adults at recommended doses. The most commonly reported side effects are loose stools, gas, abdominal cramping, astringent aftertaste. Use caution if any of these apply to you: Pregnancy (Haritaki/Triphala traditionally avoided); Acute diarrhea or active GI inflammation; Severe dehydration.
Psyllium Husk
Likely helpsGel-forming soluble fiber that lowers LDL cholesterol, regulates blood sugar, and promotes digestive regularity.
Resistant Starch
Likely helpsBypasses small intestine digestion to feed colon bacteria that produce butyrate — supports blood sugar, gut integrity, and metabolic health.
Green Tea Extract
Likely helpsConcentrated catechins from green tea that support metabolism, fat oxidation, brain health, and antioxidant defense.
Artichoke Extract
Likely helpsCynarin and chlorogenic acid stimulate bile production, support liver function, and modestly lower cholesterol levels.
Explore: Best supplements for Body HealthBest supplements for Vitality & Longevity
Reviewed by Dr. Baher Al Hakim · Last reviewed June 2026 · evidence from 22 studies · how we score · editorial policy
This information is for educational purposes only. It is not a substitute for professional medical advice. Always consult a qualified healthcare provider before starting, stopping, or changing any supplement or medication.
Tap node to isolate • Pinch to zoom • Tap edge for research